Michael Scolaro

Michael Scolaro

Oct 06, 2017

Group 6 Copy 232
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Crowdcuring the Blues: People, Technology and Research Against Depression

Depression is not a choice, but we can choose to do something about it. Depression is a single label used...

Improving Collaborations for Neglected Tropical Diseases

Neglected tropical diseases (NTDs) infect over a billion of the poorest people in the world, yet only a...

Can we find a low cost solution to store temperature sensitive enzymes in research?

Temperature-sensitive reagents are common in biology labs, and often need to be stored in expensive ultra...

Backer Badge Funded